Suzhou GenePharma Co., Ltd.
PrivateLast Round
Private Equity
Feb 7, 2024
Est. Valuation
$124.74M
Total Funding Raised
$7.88M
Company Overview
Suzhou GenePharma Co., Ltd. is a biotechnology company that researches, develops, and manufactures RNA-based technologies, including siRNA, miRNA, and CRISPR products, as well as providing oligonucleotide research and development services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou GenePharma Co., Ltd. Comparables
Compare Suzhou GenePharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Tsingke Biotech Co., Ltd. | 81% | |
| SIRION Biotech | 77% | |
| BBI Life Sciences Corporation | 75% |
Suzhou GenePharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 7, 2024 | ||||
| Private Equity | Jul 19, 2021 | ||||
| Private Equity | Aug 17, 2017 | ||||
| Private Equity | Feb 18, 2016 | ||||
| Angel | Feb 1, 2008 |
Key People
Founding team and executive leadership
Suzhou GenePharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Angel |
| Guosen Securities | Private Equity |
| Guoxin Securities Co., Ltd. | Private Equity |
| 华融瑞泽投资管理有限公司 | Private Equity |
| Suzhou Industrial Park Venture Capital Guidance Fund | Private Equity |
| Everbright Securities Company | Private Equity |
| Zhongtai Securities | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2025
Grew 144% QoQ, from 18 to 44 employees.
- Feb 7, 2024
$3.54M round raised
Suzhou GenePharma Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Suzhou GenePharma Co., Ltd.'s valuation, stock price, and market status.
Is Suzhou GenePharma Co., Ltd. a public or private company?
Suzhou GenePharma Co., Ltd. is a private company.
What is the current stock price of Suzhou GenePharma Co., Ltd.?
Suzhou GenePharma Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Suzhou GenePharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Suzhou GenePharma Co., Ltd. worth (valuation)?
Suzhou GenePharma Co., Ltd.'s valuation is estimated at $124.7M based on funding round data.
Can I buy Suzhou GenePharma Co., Ltd. stock?
Suzhou GenePharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Suzhou GenePharma Co., Ltd.'s last funding round?
Suzhou GenePharma Co., Ltd.'s most recent funding round was Private Equity on February 7, 2024.
Who are the main investors in Suzhou GenePharma Co., Ltd.?
Key investors in Suzhou GenePharma Co., Ltd. include Oriza Holdings, Guosen Securities, Guoxin Securities Co., Ltd., 华融瑞泽投资管理有限公司, Suzhou Industrial Park Venture Capital Guidance Fund.
Will Suzhou GenePharma Co., Ltd. IPO soon?
No public IPO plans have been announced for Suzhou GenePharma Co., Ltd..
How can I track Suzhou GenePharma Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Suzhou GenePharma Co., Ltd.'s shares on secondary markets.